Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q2 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $1.47 million versus the consensus estimate of $1.43 million.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.